Maalox 40 Chewable Tablets Antacid 400 mg + 400 mg

€13.90
Tax included
Brand
Minsan
020702054
100% secure payments
Hurry up! Only 6 item(s) left in Stock!
Quantity

WARNINGS
Aluminum hydroxide can cause constipation and an overdose of magnesium salts can cause hypomotility of the intestine; high doses of this medicine may cause or aggravate intestinal obstruction and ileus in patients at higher risk, such as those with renal impairment, with underlying constipation, with impaired intestinal motility, in children (0 to 24 months), or elderly. Aluminum hydroxide is not well absorbed from the gastrointestinal tract, and systemic effects are therefore rare in patients with normal renal function. However, excessive doses or long-term use, or even normal doses in patients with low phosphorus diets or in children (0 to 24 months), can lead to phosphate elimination (due to an aluminum-phosphate bond) accompanied by an increase in bone resorption and hypercalciuria with risk of osteomalacia. It is advisable to consult your doctor in case of long-term use or in patients at risk of hypophosphataemia. In patients with renal impairment, plasma levels of aluminum and magnesium tend to increase causing hyperalluminaemia and hypermagnesaemia respectively. In these patients, long exposures to high doses of aluminum and magnesium salts can lead to encephalopathies, dementia, microcytic anemia or worsening of dialysis osteomalacia. In the presence of mild and moderate forms of renal insufficiency it is recommended to take the product under the direct supervision of the doctor. Prolonged use of the medicinal product should be avoided in these patients. Aluminum hydroxide may not be safe in patients with porphyria undergoing hemodialysis. Oral suspension parahydroxybenzoates and sorbitol. Chewable tablets contain sorbitol and sucrose.
PHARMACOTHERAPEUTIC CATEGORY
Antacids.
STORAGE
Oral suspension 3.65% + 3.25%: do not store below 4 degrees C. Keep the bottle tightly closed.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active ingredients or to any of the excipients; patients with porphyria; severe forms of renal failure; generally contraindicated in pediatric age; state of cachexia.
NAME
MAALOX
EXCIPIENTS
Oral suspension 3.65% + 3.25%: methyl parahydroxybenzoate, propyl parahydroxybenzoate, citric acid monohydrate, non crystallizable liquid sorbitol, mannitol, mint essence, sodium saccharin, purified water. Chewable tablets 400 mg + 400 mg: sucrose powder with starch, sorbitol, mannitol, magnesium stearate, mint flavoring powder, sodium saccharin, sucrose.
SIDE EFFECTS
The frequency of the undesirable effects reported below is defined using the following conventions: common (> = 1/100, <1/10); uncommon (> = 1 / 1,000, <1/100); rare (> = 1 / 10,000, <1 / 1,000); very rare (<1 / 10,000); not known. Disorders of the immune system. Not known: angioedema, anaphylactic reactions, hypersensitivity reactions, urticaria, pruritus. Gastrointestinal disorders. Uncommon: diarrhea or constipation. Metabolism and nutrition disorders. Not known: hypermagnesaemia, hyperalluminaemia, hypophosphataemia, during prolonged use or at high doses or even at normal doses of the drug in patients with low phosphorus diets or in children (0 to 24 months), which can cause an increase in bone resorption, hypercalciuria, osteomalacia. The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug.
PREGNANCY AND BREASTFEEDING
The medicine should be used only in case of need ', after evaluating the expected benefit to the mother in relation to the possible risk to the fetus or infant. Due to limited maternal absorption when taken according to the indicated dosage regimen, aluminum hydroxide and its combinations with magnesium salts are considered compatible with breastfeeding.
INDICATIONS
Symptomatic treatment of occasional heartburn and hyperacidity of the stomach.
INTERACTIONS
Since 'Al and Mg salts reduce the gastrointestinal absorption of tetracyclines, it is recommended to avoid taking the drug during oral tetracycline therapy. The use of aluminum-containing antacids can reduce the absorption of drugs such as H2 antagonists, atenolol, cefdinir, cefpodoxime, chloroquine, tetracyclines, diflunisal, digoxin, bisphosphonates, ethambutol, fluoroquinolones, sodium fluoride, glucocorticoids, indomethacin, isoniazid , ketoconazole, levothyroxine, lincosamides, metoprolol, phenothiazine neuroleptics, penicillamines, propranolol, rosuvastatin, iron salts. Polystyrene sulphonate (Kayexalate): caution is recommended when the medicinal product is taken together with polystyrene sulfonate (Kayexalate) due to the potential risk of reduced efficacy of the resin in binding potassium, of metabolic alkalosis in patients with renal impairment (reported with hydroxide of aluminum and magnesium hydroxide), and intestinal obstruction (reported with aluminum hydroxide). Aluminum hydroxide and citrates can cause hyperalluminaemia, especially in patients with renal impairment. Allow at least two hours (4 for fluoroquinolones) before taking the medicine to avoid interaction with other drugs. Concomitant use of quinidine may result in increased serum quinidine levels and lead to quinidine overdose. The simultaneous use of aluminum hydroxide and citrates can lead to an increase in aluminum levels, particularly in patients with renal insufficiency.
DOSAGE
Oral suspension 3.65% + 3.25%: ingest 2 to 4 teaspoons or 1 - 2 sachets of oral suspension 4 times a day, 20 - 60 minutes after meals and at bedtime. Method of administration: shake well before use. It can also be taken in water or milk. Chewable tablets 400 mg + 400 mg: 1-2 tablets 4 times a day well chewed or sucked, 20 - 60 minutes after meals and before bedtime. Method of administration: The tablets should be well chewed or sucked. Their intake can be followed by the ingestion of water or milk. Pediatric population: pediatric administration of the drug is not recommended. Do not exceed the maximum dose indicated.
ACTIVE PRINCIPLES
Magnesium hydroxide 3.65 g; aluminum hydroxide 3.25 g.
Sanofi
020702054
6 Items

Specific References

chat Comments (0)
No customer reviews for the moment.

Maalox 40 Chewable Tablets...

€13.90